Cytokinetics | CYTK - Pre Tax Profit

Stock Price
62.33
Daily Change
-0.31 -0.49%
Monthly
-4.32%
Yearly
35.49%
Q1 Forecast
65.83

Cytokinetics reported $-183.03M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 26.32M 18.28M Dec/2025
Amgen USD 3.92B 2.35B Sep/2025
Arca Biopharma USD -21M 4.78M Mar/2025
Bayer EUR -1.16B 735M Sep/2025
Biogen USD 557.3M 186.7M Sep/2025
Brainstorm Cell Therapeutics USD -2.86M 109K Mar/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Capricor Therapeutics USD -24.39M 17.27M Mar/2025
Cytokinetics USD -183.03M 123.15M Dec/2025
Eisai JPY 22B 7.47B Dec/2025
Eli Lilly USD 7.23B 456M Sep/2025
Exelixis USD 252.69M 275K Dec/2025
Geron USD -31.14M 12.72M Dec/2025
Halozyme Therapeutics USD 218.96M 14.02M Sep/2025
Ionis Pharmaceuticals USD -228M 99M Dec/2025
Ligand Pharmaceuticals USD 141.14M 102M Sep/2025
Merck USD 6.74B 22M Sep/2025
Novartis USD 4.2B 335M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
Regeneron Pharmaceuticals USD 1.76B 244.6M Sep/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sanofi EUR -1.16B 5.5B Dec/2025